Randomised controlled trial of ketamine augmentation of electroconvulsive therapy to improve neuropsychological and clinical outcomes in depression (Ketamine-ECT study)
Background: Electroconvulsive therapy (ECT) is the most effective acute treatment for severe depression, but there are concerns about its adverse cognitive effects. ECT may impair cognition through stimulation of glutamate receptors, and preliminary evidence has suggested that ketamine, a glutamate...
Main Authors: | Ian M Anderson, Andrew Blamire, Tim Branton, Sabrina Brigadoi, Ross Clark, Darragh Downey, Graham Dunn, Andrew Easton, Rebecca Elliott, Clare Elwell, Katherine Hayden, Fiona Holland, Salman Karim, Jo Lowe, Colleen Loo, Rajesh Nair, Timothy Oakley, Antony Prakash, Parveen K Sharma, Stephen R Williams, R Hamish McAllister-Williams |
---|---|
Format: | Article |
Language: | English |
Published: |
NIHR Journals Library
2017-03-01
|
Series: | Efficacy and Mechanism Evaluation |
Online Access: | https://doi.org/10.3310/eme04020 |
Similar Items
-
A review of ketamine’s role in ECT and non-ECT settings
by: Jankauskas V, et al.
Published: (2018-06-01) -
Ketamine and electroconvulsive therapy pairing in depression and mood disorders
by: Samet Kose, et al.
Published: (2017-04-01) -
Intravenous Ketamine Therapy vs. Electroconvulsive Therapy in Depressive Cases
by: Gholam Reza Kheirabadi, et al.
Published: (2012-01-01) -
Dexmedetomidine for the management of postictal agitation after electroconvulsive therapy with S-ketamine anesthesia
by: Aksay SS, et al.
Published: (2017-05-01) -
BDNF and the Antidepressant Effects of Ketamine and Propofol in Electroconvulsive Therapy: A Preliminary Study
by: Huang XB, et al.
Published: (2020-04-01)